GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
exon
Synonyms
Noun
1. coding DNA
2. deoxyribonucleic acid, desoxyribonucleic acid, DNA
Usage
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53® - Sarepta Therapeutics
U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations - Nature
Sunvozertinib Outperforms Chemotherapy as First-Line Therapy for EGFR Exon 20–Mutant NSCLC - Targeted Oncology
Emerging TKIs Drive Renewed Progress in EGFR Exon 20 Insertion–Positive NSCLC - OncLive
Sunvozertinib in NSCLC With EGFR Exon 20 Insertion Mutations - The ASCO Post
Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne Muscular Dystrophy - NeurologyLive
Houston Dynamo FC loan forward Exon Arzú to Real C.D. España in Honduras - Houston Dynamo FC
Ascidian and Lilly Enter Global Research Collaboration to Develop RNA Exon Editors for Devastating Kidney Diseases - PR Newswire
First-Line Sunvozertinib Demonstrates Superior Efficacy Over Chemo in Advanced NSCLC With EGFR Exon 20 Insertions - ASCO Daily News
Exonerating the exon: what happens when the genome loses its instructions? - Wellcome Sanger Institute Blog
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases - Genetic Engineering and Biotechnology News
MET and Lung Cancer - American Lung Association
Sunvozertinib Shows Superior Efficacy vs Chemo in Frontline Advanced EGFR Exon 20+ NSCLC - OncLive
Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics - Nature
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53® - Sarepta Therapeutics
Phylogenomic profile of exon-intron organization across angiosperms, their relationships with protein domains, and functional implications - Nature
FDA Accepts NDA for Zipalertinib in Locally Advanced or Metastatic EGFR Exon 20+ NSCLC - OncLive
A portable poison exon for small-molecule control of mammalian gene expression - Nature
Sunvozertinib Monotherapy Bests Platinum-Doublet Chemotherapy in EGFR Exon 20+ NSCLC - OncLive
Recombinant GBA1 alleles presenting as exon-level deletions by short-read NGS in Parkinson disease: Implications for diagnostic approaches - Nature
A decade ago, these drugs tore apart the FDA. Today, they might be some patients' best hope - STAT
DMD Treatment Toolkit: Corticosteroids, Exon Skipping, and Gene Therapy - NeurologyLive
Kansas Supreme Court upholds Exon’s conviction in daughter’s death - KCTV
Sarepta’s DMD Exon-Skippers Fail Confirmatory Study, Stock Craters - BioSpace
The Landscape of EGFR Exon 20-Positive Lung Cancer Treatment - Targeted Oncology
Gene regulation through exon junction complex modularity - Nature
Exceptional response to furmonertinib in lung adenocarcinoma harboring HER2 exon 20 insertion mutation: a case report - Frontiers
Lilly, Ascidian enter $1.9B pact to develop RNA exon editors for kidney diseases - FirstWord Pharma
Dyne Therapeutics’ Exon Skipping Duchenne Therapy Delivers Good Results - Inside Precision Medicine
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity - Nature
Dyne Plans Post-Prasad FDA Run as Duchenne Exon Skipper Sustains Benefit in Long Term Data - BioSpace
SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation - Nature
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC - AJMC
Acyclovir-Activated Poison Exon Enables Reversible Gene Expression - Genetic Engineering and Biotechnology News
Andamertinib Effective in NSCLC With EGFR Exon 20 Insertion Mutation - AJMC
Exon-skipping therapy shows promise for DMD44 - Muscular Dystrophy News
EGFR and Lung Cancer - American Lung Association
Lilly, Ascidian link up in RNA exon editing pact - BioPharma Dive
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B - BioSpace
Genetic and clinical characteristics of Japanese cystinuria with exon and exon–intron boundary variants - Nature
Targeted Strategies Push the Envelope for BRAF V600E–, MET Exon 14–, and KRAS G12C–Mutated Metastatic NSCLC - OncLive
Kansas Supreme Court upholds Exon’s conviction in daughter’s death - WIBW
Case Report: A de novo NSD2 multiple exon deletion variant in a child with Rauch-Steindl syndrome - Frontiers
Sarepta Plans FDA Run for Duchenne Exon Skippers Despite Confirmatory Trial Failure - BioSpace
Exon-skipping approach boosts levels of key Rett syndrome protein - The Transmitter
Exon-skipping DMD therapy gets FDA orphan drug status - Muscular Dystrophy News
Dyne readies FDA push after DMD exon 51 med excels in trial - Fierce Biotech
EGFR Exon 19 Deletion NSCLC With MET Amplification and TP53 Mutation: What Is the Optimal First-Line Approach? - CancerNetwork
Dyne’s Exon Skipper Delivers ‘Best Ever’ Functional Outcomes in Early DMD Study - BioSpace
Sunvozertinib Approval Fills Treatment Gap in Pretreated EGFR Exon 20–Mutant NSCLC - OncLive
INCA033989 With/Without Ruxolitinib Drives Spleen and Anemia Responses in CALR Exon 9–Mutated Myelofibrosis - OncLive
Case Report: Perioperative application of trastuzumab deruxtecan in HER2 exon 20 mutation-positive non-small cell lung cancer - Frontiers
Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing - Nature
Analyses of exon 4a structure reveal the properties of Big tau related to distribution, function and aggregation - Frontiers
Furmonertinib plus pemetrexed in the treatment of EGFR exon 19 deletion lung adenocarcinoma: two case reports - Frontiers
PYM1 limits non-canonical Exon Junction Complex occupancy in a gene architecture dependent manner to tune mRNA expression - Nature
Application of Exon Primed Intron Crossing Markers to Cross-Amplify Oreochromis Species in Eastern Africa - Wiley Online Library
Tepotinib Generates Superior Responses in Adenocarcinoma vs Non-Adenocarcinoma MET Exon 14 Skipping NSCLC - OncLive
Richard Exon: Amid flags, fans, friction and football, brands must avoid lazy patriotism - The Drum
Pooled Analysis Shows Manageable Safety Profile With Tepotinib in MET Exon 14+ NSCLC - OncLive
RYR2 Exon 3 Deletion as a Cause of Convergent Catecholaminergic Polymorphic Ventricular Tachycardia and Cardiomyopathy - American Heart Association Journals
Dr Xia on the Differences Between ctDNA Monitoring Strategies in MET Exon 14–Mutant NSCLC - OncLive
Alternative Splicing of Exon 23a in Neurofibromatosis Type 1 Pre-mRNA: Its Contribution to the Protein Structure and Function of Neurofibromin - Wiley Interdisciplinary Reviews
Sarepta to ask FDA for full approval of exon skipping drugs; Rhythm's label expansion in rare form of obesity - Endpoints News
Long-read RNA sequencing unveils a novel cryptic exon in MNAT1 along with its full-length transcript structure in TDP-43 proteinopathy - Nature
Avidity shares functional data ahead of plans to submit Duchenne exon skipping drug by year's end - Endpoints News
Jeffrey Chamberlain, PhD, on Considerations for Exon Skipping and Gene Therapy in DMD - CGTLive®
FDA Grants Accelerated Approval to Sunvozertinib for EGFR Exon 20 Insertion Mutations in NSCLC - Oncodaily
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model - Nature
DG9 boosts PMO nuclear uptake and exon skipping to restore dystrophic muscle and cardiac function - Nature
DOLPHIN advances single-cell transcriptomics beyond gene level by leveraging exon and junction reads - Nature
Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects - Nature
Structural insights into the cross-exon to cross-intron spliceosome switch - Nature
Houston Dynamo FC sign Honduran National Team attacker Exon Arzú on full transfer from Real C.D. España - Houston Dynamo FC
Recent Developments in Targeting EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer - ASCO Daily News
DMD treatment: Exon-skipping therapies - Muscular Dystrophy News
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease - Nature
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib | Leukemia - Nature
MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience - Nature
Differential exon usage of developmental genes is associated with deregulated epigenetic marks - Nature
Takeda to Voluntarily Withdraw Mobocertinib for EGFR Exon 20 Insertion+ NSCLC - OncLive
EGFR Exon 20 Lung Cancer – New Treatment Options and Detection Methods - American Lung Association
Academia Sinica - Research Findings | New mechanistic insights into Prp22-mediated exon ligation and mRNA release - sinica.edu.tw
Regulation of micro- and small-exon retention and other splicing processes by GRP20 for flower development - Nature
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters - Nature
Exon architecture controls mRNA m6A suppression and gene expression - Science | AAAS
Structural insights into human exon-defined spliceosome prior to activation - Cell Research - Nature
EGFR Therapies Fail to Benefit Patients With NSCLC and Exon 20 Insertions - Targeted Oncology
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial - The Lancet
Exon junction complex shapes the m - Nature
Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue - Nature
FDA Grants Accelerated Approval to Sunvozertinib for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations - OncLive
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer - Nature
Exon-variant interplay and multi-modal evidence identify endocrine dysregulation in severe psychiatric disorders impacting excitatory neurons | Translational Psychiatry - Nature
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5 - Nature
Template-jumping prime editing enables large insertion and exon rewriting in vivo - Nature
Phase 1/2 trial of exon 44 skipping therapy for DMD cleared in UK - Muscular Dystrophy News
Exon-junction complex association with stalled ribosomes and slow translation-independent disassembly - Nature
Alternatively spliced mini-exon B in PTPδ regulates excitatory synapses through cell-type-specific trans-synaptic PTPδ-IL1RAP interaction - Nature
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations - The New England Journal of Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'exon'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
expn, exin, exoon, exom, eon, exo, xeon, exxon, exno, eexon, rxon, wxon, eoxn, exonn, ezon, xon, econ, exn, exob
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z